Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved tags : Covid-19 save search
Novavax's Updated COVID-19 Vaccine Now Approved in the EU
Published: 2023-10-31 (Crawled : 21:00) - prnewswire.com
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 0.6%
H: 5.22%
C: 4.48%
covid-19 vaccine approved
Novavax's Prototype COVID-19 Vaccine Nuvaxovid™ Receives Full Approval in Singapore
Published: 2023-10-18 (Crawled : 13:30) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -0.78%
H: 2.5%
C: 1.09%
covid-19 vaccine prototype approval
FDA Panel Sets Possible Precedent; Novavax Wins Approval for Updated COVID-19...
Published: 2023-10-05 (Crawled : 17:00) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M
|
Health Technology
|
| O: 0.4%
H: 2.05%
C: 1.82%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.4%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: 0.0%
covid-19 fda approval
FDA Panel Sets Possible Precedent; Novavax Wins Approval for Updated COVID-19 Vaccine
Published: 2023-10-05 (Crawled : 15:30) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M
|
Health Technology
|
| O: 0.4%
H: 2.05%
C: 1.82%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.4%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: 0.0%
covid-19 fda vaccine approval
Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine
Published: 2023-09-11 (Crawled : 20:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.03%
H: 0.18%
C: -0.88%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.65%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -0.49%
H: 0.2%
C: -1.33%
covid-19 fda vaccine approval
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine
Published: 2023-09-11 (Crawled : 20:00) - biospace.com/
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: -0.78%
H: 0.42%
C: -0.94%
covid-19 fda vaccine approval
FDA Approves Veklury® (Remdesivir) to Treat COVID-19 in People With Mild to Severe Hepatic Impairment With no Dose Adjustment
Published: 2023-08-24 (Crawled : 18:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.27%
H: 1.15%
C: -1.19%
covid-19 veklury fda treat
FDA Approves Veklury® (Remdesivir) for COVID-19 Treatment in Patients With Severe Renal Impairment, Including Those on Dialysis
Published: 2023-07-14 (Crawled : 14:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.13%
H: 1.34%
C: 0.76%
covid-19 veklury fda renal treatment dialysis
Pfizer’s PAXLOVID™ Receives FDA Approval for Adult Patients at High Risk of Progression to Severe COVID-19
Published: 2023-05-25 (Crawled : 21:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.31%
H: 0.0%
C: -1.77%
covid-19 fda approval risk
Aethlon Medical Receives Ethics Board Approval to Add Second Site to its Ongoing Clinical Trial of its Hemopurifier® to Treat Severe COVID-19 in India
Published: 2023-05-22 (Crawled : 12:00) - prnewswire.com
AEMD A | $1.5 6.01% 5.67% 18K
|
Health Technology
|
| O: -0.8%
H: 8.03%
C: 4.13%
covid-19 hemopurifier approval india ongoing medical trial
GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate
Published: 2023-02-01 (Crawled : 14:00) - biospace.com/
GRNA | $0.2995 -0.03% -0.07% 0
|
Professional, Scientific, and T...
|
| O: 6.24%
H: 0.0%
C: -5.87%
covid-19 candidate vaccine mrna trial approval
Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster
Published: 2023-01-18 (Crawled : 14:20) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 1.53%
H: 8.47%
C: -1.19%
covid-19 vaccine approved nuvaxovid
Bioxytran Receives Approval to Optimize Dosage in COVID-19 Patients
Published: 2022-12-08 (Crawled : 13:20) - biospace.com/
BIXT A | $0.1285 490.75% 32K
|
Professional, Scientific, and T...
|
| O: 4.78%
H: 0.0%
C: 0.0%
covid-19 approval
Novavax Nuvaxovid COVID-19 Vaccine Approved in Canada for Use as a Primary Series in Adolescents
Published: 2022-12-07 (Crawled : 16:00) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 0.0%
H: 6.02%
C: 2.62%
covid-19 vaccine canada approved nuvaxovid
Press Release: Sanofi and GSK’s next-generation COVID-19 booster vaccine VidPrevtyn® Beta approved by the European Commission
Published: 2022-11-10 (Crawled : 16:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -3.15%
H: 4.22%
C: 4.22%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 3.05%
H: 0.0%
C: 0.0%
covid-19 vidprevtyn vaccine approved sanofi
Ministry of Health, Labour and Welfare in Japan Approves Partial Change to a New Drug Authorization for Moderna's Omicron-Targeting Bivalent Booster COVID-19 Vaccine, mRNA-1273.222
Published: 2022-11-01 (Crawled : 09:00) - biospace.com/
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: 2.95%
H: 2.66%
C: -0.1%
covid-19 drug japan change authorization
Dyadic Receives Regulatory Approval to Initiate Phase 1 Clinical Trial to Demonstrate Clinical Safety and Efficacy in Humans for DYAI-100 COVID-19 Recombinant Protein RBD Booster Vaccine Candidate
Published: 2022-10-27 (Crawled : 13:00) - globenewswire.com
DYAI A | $1.61 1.26% 1.24% 14K
|
Health Technology
|
| O: 4.65%
H: 0.44%
C: -1.78%
dyai-100 covid-19 candidate vaccine trial approval
Vaxxinity Completes Enrollment in Pivotal Phase 3 Clinical Trial of UB-612 COVID-19 Vaccine Heterologous Booster Candidate and Initiates Rolling Submission for Provisional Approval in Australia
Published: 2022-10-24 (Crawled : 18:00) - biospace.com/
VAXX | News | $0.4761 2.43% 2.37% 290K
|
|
| O: -1.32%
H: 0.15%
C: -5.33%
ub-612 covid-19 candidate australia vaccine trial approval submission
Global Vehicle Electrification Market Analysis Report 2022: Opportunities, Regulatory Scenario, Industry Trends, Merger and Acquisitions, New System Launch/Approvals, Impact of COVID-19 Pandemic
Published: 2022-09-13 (Crawled : 10:00) - prnewswire.com
DNZOY | $18.47 0.08% 47K
|
Manufacturing
|
| O: -0.31%
H: 0.0%
C: -2.18%
KT | $12.2 0.25% 0.0% 340K
|
Communications
|
| O: -1.56%
H: 0.23%
C: -1.59%
BWA | $32.8 2.15% 0.0% 2.2M
|
Producer Manufacturing
|
| O: -3.04%
H: 1.26%
C: -0.76%
covid-19 global system report impact market
Ministry Of Health, Labour and Welfare in Japan Approves Partial Change to a New Drug Authorization for Moderna's Omicron-Targeting Bivalent Booster COVID-19 Vaccine, mRNA-1273.214
Published: 2022-09-12 (Crawled : 12:00) - biospace.com/
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: -0.2%
H: 1.96%
C: -1.18%
covid-19 drug japan authorization
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.